Browse conferences
Fields
All fields →
Health & Medicine
Computing & Data
Engineering & Technology
Arts & Humanities
Social & Behavioural Sciences
Physical Sciences
Earth & Environment
Education
Business & Economics
Life Sciences
Agriculture & Veterinary
Politics & Public Policy
Law & Criminology
Mathematics & Statistics
Open callsBlogFor organizersAdd your event — freeLog inSign up
This edition has ended.4th World Congress of Biopharm Industry Development (BID-2025) was held 24–26 Sept 2025 in Shanghai. The information below is kept for reference.
Follow the series

4th World Congress of Biopharm Industry Development (BID-2025)

Part of the World Congress of Biopharm Industry Development (BID-) series →

Dates24–26 Sept 2025
LocationShanghai, China
SubmissionsNot listed
RegistrationClosed
FormatIn person
FieldLife Sciences · Biotechnology
OrganizerNot listed

About & call for papers

The field of biopharma has always been at the forefront of global scientific, medical, and commercial innovation. From gene editing and personalized medicine to cell therapy and novel treatment options, biopharma is evolving at an unprecedented pace, offering… Read more

The field of biopharma has always been at the forefront of global scientific, medical, and commercial innovation. From gene editing and personalized medicine to cell therapy and novel treatment options, biopharma is evolving at an unprecedented pace, offering new therapeutic choices to patients worldwide. The 4th World Congress of Biopharm Industry Development (BID-2025) will take place in Fengxian, Shanghai, from September 24-26, 2025, with the theme "Bridging Global High-end Talents, Empowering Industrial Innovation". This conference aims to be one of the most significant events in the global biopharma field in 2025, providing an exceptional platform for exchange, collaboration, and the shaping of the future direction of the biopharmaceutical industry. The conference will feature a variety of activities, including: Keynote speeches by leading experts, scientific forums and panel discussions, Exhibitions and poster presentations, Networking opportunities, Site visits. In addition, seven specialized forums will focus on key areas of biopharma, including: Frontier Research in Drug Discovery, Cutting-Edge Drug Discovery Technologies, Drug Discovery Chemistry Innovation, Novel Drug Delivery Technologies and Systems, Gene and Cell Therapy Innovation & Development, Next-Generation Protein and Peptide Drugs, Pharmaceutical Process Development & Manufacturing. As always, this conference is dedicated to fostering mutual support and intellectual exchange among scientists and industry leaders from around the globe. We sincerely invite global talents to join us in Shanghai, where they can contribute to revitalizing international cooperation and advancing the Chinese biomedicine industry to the forefront of global innovation. Call For: - Co-Organizers, Supporting Organizations - Collaborative Partners, Mediasand Journals - Speakers, Chairs, Exhibitors, Attendee, Papers and Posters Contact Us: For Speech Opportunity For Media Sponsorship and Media Partnership For Sponsorship and Exhibition Opportunity Ms. Elsa Email: [email protected] Tel: 0086-411-84799629 Ms. Irene Email: [email protected] Tel: 0086-411-84799629 Ms. Alma Email: [email protected] Tel: 0086-411-84799629

Venue

Nanjiao Hotel Shanghai (5-star Hotel)

No.8 Wangyuan Road, Najiao New City, Shanghai, China

Shanghai, China

Open Nanjiao Hotel Shanghai (5-star Hotel) in maps ↗

The address is as the organizer gave it, and it is not checked against a map.

Similar conferences

Frequently asked

When is the 4th World Congress of Biopharm Industry Development (BID-2025) submission date?
This edition has ended. The series page shows whether a newer edition is accepting submissions.
Where was 4th World Congress of Biopharm Industry Development (BID-2025) held?
It was held at the Nanjiao Hotel Shanghai (5-star Hotel), Shanghai, China.
Can I attend 4th World Congress of Biopharm Industry Development (BID-2025) remotely?
No — this edition is listed as in person only.